Give a highly ranked research and teaching facility access to cutting-edge technology, and the results could be death ...
Stents Drug Eluting
This channel includes news and new technology innovations for drug eluting stents (DES). These drug coated stents were developed to solve a frequent problem with bare metal stents, which can cause neointimal hyperplasia (scar tissue growth) in some patients. The antiproliferative drugs used on DES prevent the growth of tissue. One downside of DES is the requirement for patients to take long-term antiplatelet therapy to prevent the possible formation of clots on these stents. Newer generation DES use technologies help the vessels heal faster, which may allow reduce the duration of dual antiplatelet therapy (DAPT), or use a single drug, usually eliminating aspirin. This section includes news for both metallic and bioresorbable drug-eluting stents and related clinical trial data.
![](/sites/default/files/styles/content_feed_large/public/field/image/28122_3.jpg?itok=idaVC0Yp)
The drug-eluting stent (DES) market is a multibillion dollar business in the U.S. — and it's estimated that over three ...